Digital Health Global
OCTOBER 23, 2023
CRNSV”) was formed by former executives and directors of Nymox Pharmaceutical Corporation (“Nymox” or the “Company”), who were improperly removed from their positions, with a goal to recover shareholder value in Nymox. & LONDON–(BUSINESS WIRE)– The Committee to Restore Nymox Shareholder Value, Inc.
Digital Health Global
FEBRUARY 5, 2024
TVM’s portfolio focuses on therapeutics and medical technologies from North America and the EU that represent differentiated first-in-class or best-in-class assets with the potential to transform standard of care. TVM also invests in differentiated commercial-stage medical technologies and late clinical-stage therapeutics.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Lloyd Price
MARCH 16, 2024
This could include discussions on healthcare disparities and strategies for achieving better health outcomes for all. In addition to these core areas, there will likely be discussions on specific sectors within healthcare, such as pharmaceuticals, medical management, and healthcare delivery models. Subscribe Today!
Health Populi
APRIL 1, 2022
To scale what works, based on evidence and proven interventions — which depends on our reducing biases in our assumptions, models and strategies. To innovate more, and more quickly, across the entire ecosystem of health — in government policies, pharmaceutical innovations, and technology developments.
Healthcare IT Today
JANUARY 25, 2024
Recognizing the industry transformation taking place as digital innovation reshapes the experience of patients and providers, GE HealthCare – a leading global medical technology, pharmaceutical diagnostics, and digital innovator – is focused on developing smart devices, aligned to disease states and enabled by digital.
Digital Health Global
FEBRUARY 9, 2024
As we delve into the future of medical technology, several key developments emerge as pivotal in shaping the next wave of healthcare innovation. Digital Therapeutics (DTx) The use of digital tools to treat medical conditions, either as standalone therapies or in conjunction with traditional pharmaceuticals, is only set to grow.
Healthcare IT Today
JANUARY 5, 2024
Healthcare providers, researchers, pharmaceutical companies, and medical technology specialists will all need to take a phased approach to deploying new technologies. What’s further, an incremental approach to technological advancement will allow leaders to stay on task and build out their strategy carefully.
Expert insights. Personalized for you.
88 
Let's personalize your content